• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipCDC

The New CDC Director Is Taking a Salary Cut After Congress Asked Questions About His Massive Raise

By
Hallie Detrick
Hallie Detrick
Down Arrow Button Icon
By
Hallie Detrick
Hallie Detrick
Down Arrow Button Icon
May 1, 2018, 6:21 AM ET
Robert-Redfield-CDC-Director
This undated photo provided by the University of Maryland School of Medicine in March 2018 shows Dr. Robert Redfield Jr. Photograph by Tracey Brown—University of Maryland School of Medicine/APTracey Brown—University of Maryland School of Medicine/AP

It must have been nice salary bump while it lasted.

After reporting last week showed that Dr. Robert Redfield Jr., the new director of the Centers for Disease Control and Prevention (CDC) was earning $150,000 more than his predecessors, the government has announced it will reduce his pay.

Redfield’s $375,000 salary was allowed under Title 42, a provision that allows the government to pay higher-than-standard salaries to scientists with specialized skills in order to attract them to public service. Although thousands of CDC and National Institutes of Health (NIH) employees are paid under Title 42, it is unusual to use it for the CDC director’s pay. Redfield’s two immediate predecessors were not paid under Title 42.

After last week’s reports on Redfield’s salary, Senator Patty Murray (D-Wash.) wrote to Alex Azar, Secretary of the Department of Health and Human Services, to inquire about the use of Title 42 in Redfield’s case. She questioned whether the search had been exhaustive and whether the position itself is a scientific role.

A spokesperson for the Department of Health and Human Services toldThe New York Times that Redfield “does not wish to have his compensation become a distraction for the important work of the CDC” and that his pay would be adjusted accordingly. The government declined to specify Redfield’s new salary, or indeed whether it would be determined under Title 42.

About the Author
By Hallie Detrick
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.